A Randomized Controlled Trial of AppS to Home Monitor Your Asthma

Overview

The objective of this study is to design, implement, and evaluate the impact of an adapted health information technology(IT)-enabled practice model for asthma symptom monitoring using patient-reported outcomes (PROs) in a primary care setting. Adults over 18 years of age with asthma will be recruited at primary care clinics and randomized to either 1) asthma symptom monitoring via the mobile health (mHealth) app; or 2) usual care. The investigators will collect data on patient-reported asthma quality of life and asthma-related healthcare utilization. We will also study barriers and facilitators to implementation of the mHealth app and health IT-enabled practice model.

Full Title of Study: “Integrating Patient-Reported Outcomes Into Routine Primary Care: Monitoring Asthma Between Visits”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Health Services Research
    • Masking: None (Open Label)
  • Study Primary Completion Date: April 30, 2023

Detailed Description

The specific aims of this study are: 1. Adapt our existing health IT-enabled practice model for asthma symptom monitoring using PROs to a primary care population. The health IT-enabled practice model is comprised of the following: an mHealth app that can be installed on patients' smartphones that integrates into clinical workflow; and an asthma PRO dashboard in the electronic health record (EHR) for clinicians. 2. Implement the adapted health IT-enabled practice model in 7 primary care community clinics, identify a cohort of eligible asthma patients to participate, and train clinicians and clinical staff. 3. Rigorously evaluate the impact of this new health IT-enabled practice model using a randomized controlled trial study in which we enroll 500 asthma patients (250 intervention, 250 usual care) by primary care clinician. We will measure patient-reported asthma quality of life and asthma-related healthcare utilization (defined as urgent care and emergency room visits and hospitalizations) as our primary and secondary outcomes, respectively. We will use mixed methods to identify barriers and facilitators to implementation and factors that affect sustainable spread and scale as per the Non-adoption, Abandonment, Scale-up, Spread, and Sustainability (NASSS) framework.

Interventions

  • Other: mobile health app
    • asthma symptom monitoring via a clinically integrated mobile health (mHealth) app installed on patients’ smartphones

Arms, Groups and Cohorts

  • Experimental: Intervention
  • No Intervention: Usual Care

Clinical Trial Outcome Measures

Primary Measures

  • Asthma-related patient-reported quality of life
    • Time Frame: 6 months from enrollment
    • Asthma-related patient-reported quality of life assessed using the 15-item Mini Asthma Quality of life Questionnaire (AQLQ)
  • Asthma-related patient-reported quality of life
    • Time Frame: 12 months from enrollment
    • Asthma-related patient-reported quality of life assessed using the 15-item Mini Asthma Quality of life Questionnaire (AQLQ)

Secondary Measures

  • Asthma-related healthcare utilization
    • Time Frame: 12 months from enrollment
    • Asthma-related healthcare utilization, defined as number of urgent care and emergency room visits, and number of hospitalizations.

Participating in This Clinical Trial

Inclusion Criteria

  • English- or Spanish-speaking – 18 years of age – Regularly uses (most days) a compatible smartphone (iOS or Android) – Able to provide consent – Seen for primary care within the last 12 months at one of the 7 outpatient primary care clinics that are part of the Brigham & Women's Hospital (BWH)/ Brigham & Women's Faulkner Hospital (BWFH) practice-based research network. – At least one visit coded for asthma within 12 months prior to screening, including inpatient, emergency department, urgent care/walk-in, and specialist visits. Exclusion Criteria:

  • Deemed inappropriate for study, per judgment of the BWH/ BWFH primary care provider – Unable to provide consent

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • RAND
  • Collaborator
    • Brigham and Women’s Hospital
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Robert S Rudin, PhD, Principal Investigator, RAND
    • Anuj K Dalal, MD, Principal Investigator, Mass General Brigham

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.